Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism

Methionine Sulfoximine May Improve Inflammation in Autism, A Novel Hypothesized Treatment for Autism

(2011) Ahmad Ghanizadeh   ARCHIVES OF MEDICAL RESEARCH

May lovastatin target both autism and epilepsy? A novel hypothesized treatment

(2011) Ahmad Ghanizadeh   EPILEPSY & BEHAVIOR

Oxidative pathways as a drug target for the treatment of autism

(2010) Kristi-Ann Villagonzalo et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Expression of inflammatory cytokines, Bcl2 and cathepsin D are altered in lymphoblasts of autistic subjects

(2010) Mazhar Malik et al.   IMMUNOBIOLOGY

Targeting neurotensin as a potential novel approach for the treatment of autism

(2010) Ahmad Ghanizadeh   Journal of Neuroinflammation

TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB

(2010) Laia Tolosa et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Elevated immune response in the brain of autistic patients

(2009) Xiaohong Li et al.   JOURNAL OF NEUROIMMUNOLOGY

Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects

(2009) A.M. Sheikh et al.   NEUROSCIENCE

Rapid Tumor Necrosis Factor  -Induced Exocytosis of Glutamate Receptor 2-Lacking AMPA Receptors to Extrasynaptic Plasma Membrane Potentiates Excitotoxicity

(2008) D. Leonoudakis et al.   JOURNAL OF NEUROSCIENCE